ACO Participants

  • PMA Medical Specialists, LLC

No participants are involved in a joint venture between ACO professionals and hospitals

ACO Governing Body

  • Rimmer, Timothy, 1, Voting Member and, PMA Medical Specialists, LLC
  • Eisner, Joel, 1, Voting Member, PMA Medical Specialists, LLC
  • Fiorillo, Timothy, 1, Voting Member, PMA Medical Specialists, LLC
  • Fleischer, Leroy, 1, Voting Member, PMA Medical Specialists, LLC
  • Slater, Karen, 1, Voting Member, PMA Medical Specialists, LLC
  • Kovalski, Raymond, 1, Voting Member, PMA Medical Specialists, LLC
  • Schwabe, Karl, 1, Voting Member, PMA Medical Specialists, LLC
  • Sickler, John, 1, Voting Member, Medicare Beneficiary Representative
  • Mandel, Jeff, 1, Voting Member and Chair, Aledade, Inc.

Key Clinical and Administrative Leadership

  • Executive Director: Dr. Jeff Mandel
  • Medical Directors: Dr. Timothy Fiorillo and Dr. Leroy Fleischer
  • Compliance Officer: Mr. Brian Lynch
  • Quality Assurance/Improvement Officer: Dr. Emily Maxson

ACO Committees and Committee Leaderships

  • Beneficiary Engagement Committee: Joel Eisner, Francis Foley
  • Compliance Committee: Brian Lynch, Joseph Goldschmidt
  • Evidence-Based Medicine Committee: Robert Shusman, Alan Keiser
  • Performance Improvement Committee: Karl Schwade, Eric DiCicco
  • Transitions of Care Committee: Raymond Kovalski

Composition of ACO

  • A network of individual practices of ACO professionals.

Amount of Shared Savings/Losses

  • To be completed after the conclusion of the performance year

How Shared Savings Are Distributed

10%

Reinvest in infrastructure

30%

Invested in redesigned care processes/resources

60%

Distribution to ACO Participants

100%

Primary Care Professionals

N/A

Specialists

N/A

Hospital

Payment Rule Waivers

  • No, our ACO does not utilize the SNF 3-Day Rule Waiver
  • Our ACO operates a “High Priority AWV Completion Challenge” view the Waiver

Quality Reporting

2016 Quality Performance Results:

ACO#Measure NameRateACO Mean
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.
ACO-1CAHPS: Getting Timely Care, Appointments, and Information N/A80.51
ACO-2CAHPS: How Well Your Providers Communicate N/A93.01
ACO-3CAHPS: Patients’ Rating of Provider N/A92.25
ACO-4CAHPS: Access to Specialists N/A83.49
ACO-5CAHPS: Health Promotion and EducationN/A60.32
ACO-6CAHPS: Shared Decision Making N/A75.4
ACO-7CAHPS: Health Status/Functional Status N/A72.3
ACO-34CAHPS: Stewardship of Patient Resources N/A26.97
ACO-8Risk Standardized, All Condition ReadmissionN/A14.7
ACO-35Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)N/A18.17
ACO-36All-Cause Unplanned Admissions for Patients with DiabetesN/A53.2
ACO-37All-Cause Unplanned Admissions for Patients with Heart FailureN/A75.23
ACO-38All-Cause Unplanned Admissions for Patients with Multiple Chronic ConditionsN/A59.81
ACO-9Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)N/A9.27
ACO-10Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8)N/A14.53
ACO-11Percent of PCPs who Successfully Meet Meaningful Use RequirementsN/A82.72
ACO-39Documentation of Current Medications in the Medical RecordN/A87.54
ACO-13Falls: Screening for Future Fall Risk N/A64.04
ACO-14Preventive Care and Screening: Influenza ImmunizationN/A68.32
ACO-15Pneumonia Vaccination Status for Older AdultsN/A69.21
ACO-16Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-UpN/A74.45
ACO-17Preventive Care and Screening: Tobacco Use: Screening and Cessation InterventionN/A90.98
ACO-18Preventive Care and Screening: Screening for Clinical Depression and Follow-up PlanN/A53.63
ACO-19Colorectal Cancer ScreeningN/A61.52
ACO-20Breast Cancer ScreeningN/A67.61
ACO-21Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented N/A76.79
ACO-42Statin therapy for the Prevention and Treatment of Cardiovascular DiseaseN/A77.72
ACO-27Diabetes Mellitus: Hemoglobin A1c Poor Control N/A18.24
ACO-41Diabetes: Eye ExamN/A44.94
ACO-28Hypertension (HTN): Controlling High Blood Pressure N/A70.69
ACO-30Ischemic Vascular Disease (IVD): Use of Aspirin or Another AntithromboticN/A85.05
ACO-31Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)N/A88.67
ACO-33Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)N/A79.67